Free Trial
LON:AREC

Arecor Therapeutics (AREC) Share Price, News & Analysis

Arecor Therapeutics logo
GBX 72 +1.50 (+2.13%)
As of 09/5/2025 08:23 AM Eastern

About Arecor Therapeutics Stock (LON:AREC)

Key Stats

Today's Range
70.50
72
50-Day Range
42.30
72
52-Week Range
35.40
82
Volume
26,727 shs
Average Volume
36,134 shs
Market Capitalization
£27.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AREC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AREC Stock News Headlines

Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
See More Headlines

AREC Stock Analysis - Frequently Asked Questions

Arecor Therapeutics' stock was trading at GBX 73.75 at the beginning of 2025. Since then, AREC stock has decreased by 2.4% and is now trading at GBX 72.

Arecor Therapeutics plc (LON:AREC) posted its quarterly earnings data on Tuesday, April, 22nd. The company reported ($0.31) earnings per share (EPS) for the quarter. Arecor Therapeutics had a negative net margin of 176.89% and a negative trailing twelve-month return on equity of 118.67%.

Shares of AREC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arecor Therapeutics investors own include Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Lowe's Companies (LOW) and SNDL (SNDL).

Company Calendar

Last Earnings
4/22/2025
Today
9/07/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Coal
Current Symbol
LON:AREC
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.31)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£10.68 million
Net Margins
-176.89%
Pretax Margin
N/A
Return on Equity
-118.67%
Return on Assets
-37.31%

Debt

Debt-to-Equity Ratio
5.51
Current Ratio
1.37
Quick Ratio
6.24

Sales & Book Value

Annual Sales
£5.05 million
Price / Sales
5.38
Cash Flow
GBX 14.20 per share
Price / Cash Flow
5.07
Book Value
GBX 16.58 per share
Price / Book
4.34

Miscellaneous

Outstanding Shares
37,757,000
Free Float
N/A
Market Cap
£27.19 million
Optionable
Not Optionable
Beta
-0.18
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (LON:AREC) was last updated on 9/8/2025 by MarketBeat.com Staff
From Our Partners